Australia-China Bioinnovation Roundtable 2026

​2026 Australia–China BioInnovation Roundtable

​Going Global, Together

​An official satellite event of AusBiotech's Australia's Biggest Week in Biotech
Principal partner: WuXi AppTec

​China's biotech companies have gone global fast — record out-licensing volumes and direct deals with the world's largest pharmaceutical firms. Australia has the science, the trials and the incentives, but fewer companies that have made the jump.

​Each side has something the other wants. That's the conversation.

​Our third Roundtable, held on day one of Australia's Biggest Week in Biotech — a few minutes from the convention centre, while the industry is already in town. A Shanghai venue runs alongside, so the China side speaks for itself rather than being reported secondhand.

​The 2025 edition brought together 100+ delegates across Melbourne and Shanghai, with 43,000 joining online. This one stays deliberately small: half a day, capped at 80, built around discussion rather than presentations.

​

​Who's in the room

​Biotech founders and heads of development, from pre-clinical through Phase II. Translational research leaders and commercialisation offices. R&D and partnering teams from Australian pharma. Life sciences investors and cross-border funds. Chinese biotech and pharma delegates attending Australia's Biggest Week in Biotech. R&D tax and IP advisers, CROs and trial networks.

​AusBiotech's Australia's Biggest Week in Biotech brings together the biotechnology and life sciences community for a week of sector events, collaboration and connection on the Gold Coast from 19–23 October 2026. The 2026 Australia–China BioInnovation Roundtable is proud to be an official satellite event partner.